Table 3.
BPdG adducts formed in NMECs exposed to BP in the absence (T1a) or presence (T2, T3, T4) of chlorophyllin.
| Cell Strain | T1 | T2 | T3 | T4 | % Reduction T1 vs. T4c |
|---|---|---|---|---|---|
| M98014 | 4.7 ± 0.6b | 2.2 ± 0.4 | 2.9 ± 0.2 | 2.1 ± 0.7 | 55.1c |
| M98015 | 8.3 ± 5.0 | 5.5 ± 3.3 | 5.5 ± 4.0 | 4.3 ± 4.1 | 48.2 |
| M98011 | 20.8 ± 13.0 | 15.3 ± 13.1 | 17.8 ± 9.2 | 11.7 ± 9.3 | 43.7 |
| M99003 | 7.3 ± 1.5 | 3.3 ± 0.3 | 3.5 ± 1.2 | 1.3 ± 0.4 | 82.1 |
| M99015 | 57.5 ± 16.2 | 35.0 ± 15.9 | 51.4 ± 12.1 | 35.4 ± 10.8 | 38.4 |
| M98019 | 5.1 ± 0.9 | 3.1 ± 1.3 | 3.2 ± 0.8 | 3.6 ± 1.1 | 29.5 |
| M98025 | 15.1 ± 2.4 | 5.1 ± 0.6 | 5.0 ± 1.8 | 3.7 ± 3.4 | 75.5 |
| M99021 | 13.7 ± 3.2 | 14.3 ± 1.5 | 15.3 ± 3.8 | 10.2 ± 5.4 | 25.2 |
| M00012 | 21.0 ± 4.5 | 14.7 ± 1.8 | 16.4 ± 3.5 | 10.9 ± 3.3 | 48.3 |
| M98026 | 54.5 ± 29.7 | 47.3 ± 26.0 | 42.5 ± 21.4 | 32.5 ± 18.2 | 40.3 |
| M99004 | 4.8 ± 0.5 | 2.8 ± 0.6 | 2.3 ± 1.0 | 1.9 ± 0.9 | 60.0 |
| M99016 | 34.0 ± 3.4 | 23.9 ± 3.6 | 25.5 ± 2.6 | 12.5 ± 1.4 | 63.2 |
| M99006 | 17.3 ± 3.7 | 13.6 ± 3.3 | 15.5 ± 5.8 | 12.6 ± 4.1 | 27.5 |
| M00004 | 33.4 ± 6.1 | 27.1 ± 13.7 | 28.3 ± 9.6 | 19.8 ± 12.3 | 40.7 |
| M98035 | 5.9 ± 3.9 | 2.7 ± 1.1 | 5.7 ± 1.6 | 2.7 ± 1.3 | 54.7 |
| M98030 | 9.5 ± 1.5 | 8.1 ± 3.3 | 5.5 ± 1.8 | 4.0 ± 1.6 | 57.7 |
| M99005 | 2.5 ± 1.3 | 1.3 ± 1.2 | 2.2 ± 2.3 | 1.5 ± 1.7 | 38.8 |
| M99025 | 3.2 ± 0.6 | 3.2 ± 0.2 | 2.5 ± 1.3 | 1.4 ± 0.1 | 57.1 |
| M98016 | 53.4 ± 2.5 | 26.1 ± 2.3 | 25.6 ± 7.0 | 7.0 ± 1.4 | 86.8 |
| M98013 | 23.1 ± 2.0 | 14.5 ± 2.8 | 12.2 ± 1.2 | 3.0 ± 0.9 | 87.0 |
a
T = Treatment groups as described in Section 2.
b
Number of adducts per 108 nucleotides.
c
Percentage (%) reduction in number of adducts in the T4 group compared to the T1 group.